Unique Ingredient Identifier SE337SVY37 is listed as a unspecified ingredient
| RN | 7632-05-5 |
| EC | 231-558-5 |
| NCIT | C29459 |
| RXCUI | 36709 |
UNII SE337SVY37 SODIUM PHOSPHATE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| IM - IV | INJECTION | 0.3 % |
| IM - IV | POWDER, FOR INJECTION SOLUTION | 2.48 % |
| IM - IV | SOLUTION, INJECTION | 0.17 % |
| INTRA-ARTICULAR | INJECTION | NA |
| INTRABURSAL | INJECTION | ADJPH |
| INTRADERMAL | INJECTION | 0.2 % |
| INTRALESIONAL | INJECTION | NA |
| INTRAMUSCULAR | INJECTION | 1.06 % |
| INTRAMUSCULAR | POWDER, FOR INJECTION SOLUTION | 0.1 % |
| INTRAVENOUS | INJECTION | 3.2 % |
| INTRAVENOUS | POWDER, FOR INJECTION SOLUTION | 1 % |
| IV(INFUSION) | INJECTION | 0.048 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION | 0.88 % |
| NASAL | SOLUTION | 0.19 % |
| NASAL | SPRAY | 0.468 % |
| NERVE BLOCK | INJECTION | 0.02 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.29 % |
| OPHTHALMIC | SUSPENSION | 0.2 % |
| ORAL | CAPSULE | 36 MG |
| ORAL | CONCENTRATE | NA |
| ORAL | SOLUTION | 27 MG/5ML |
| ORAL | SUSPENSION | NA |
| ORAL | SYRUP | NA |
| ORAL | TABLET | 16 MG |
| SOFT TISSUE | INJECTION | NA |
| SUBCUTANEOUS | INJECTION | 0.38 % |
| TOPICAL | EMULSION, CREAM | NA |
| TOPICAL | OINTMENT | 0.15 %W/W |
| TOPICAL | SHAMPOO | NA |
| TOPICAL | SHAMPOO, SUSPENSION | NA |